Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p23
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 23/66)
Character Range: 63647–66605

Part 1, entry for Fluconazole in the form Powder for oral suspension 50 mg in 5 mL, 35 mL
(a) omit from the column headed "Circumstances": C6006
(b) omit from the column headed "Circumstances": C6045
(c) omit from the column headed "Circumstances": C7934
(d) insert in numerical order in the column headed "Circumstances": C16114 C16141 C16148
[139] Schedule 1, Part 1, entry for Flutamide
omit from the column headed "Circumstances": C5816 substitute: C5729
[140] Schedule 1, Part 1, entry for Fremanezumab in the form Solution for injection 225 mg in 1.5 mL single dose pre-filled pen [Maximum Quantity: 1; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C14472  substitute: C16104
(b) omit from the column headed "Purposes": P14472 substitute: P16104
[141] Schedule 1, Part 1, entry for Fremanezumab in the form Solution for injection 225 mg in 1.5 mL single dose pre-filled syringe [Maximum Quantity: 1; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C14472  substitute: C16104
(b) omit from the column headed "Purposes": P14472 substitute: P16104
[142] Schedule 1, Part 1, after entry for Fulvestrant [Brand: FULVESTRANT ACCORD]
insert:
Fulvestrant  Injection 250 mg in 5 mL pre-filled syringe  Injection  FULVESTRANT-AFT  AE  MP  C11473     2  5     2

[143] Schedule 1, Part 1, entry for Galcanezumab [Maximum Quantity: 2; Number of Repeats: 1]
(a) omit from the column headed "Circumstances": C12064  substitute: C16018
(b) omit from the column headed "Purposes": P12064 substitute: P16018
[144] Schedule 1, Part 1, entries for Gliclazide in the form Tablet 80 mg
(a) omit:
Gliclazide  Tablet 80 mg  Oral  APO-Gliclazide  TX  MP NP             100  5     100
Gliclazide  Tablet 80 mg  Oral  APO-Gliclazide  TX  MP NP     P14238  200  5     100

(b) omit:
Gliclazide  Tablet 80 mg  Oral  Glyade  AF  MP NP             100  5     100
Gliclazide  Tablet 80 mg  Oral  Glyade  AF  MP NP     P14238  200  5     100

[145] Schedule 1, Part 1, after entry for Glycomacropeptide and essential amino acids with vitamins and minerals in the form Sachets containing oral powder 40 g, 30 (Camino Pro Bettermilk)
insert:
Glycomacropeptide formula with amino acids and low phenylalanine                                                         Sachets containing oral powder 12.5 g, 30 (PKU GMPro MIX-IN)  Oral  PKU GMPro MIX-IN  SB  MP NP  C4295     5  5     1
Glycomacropeptide formula with amino acids, vitamins, minerals, trace elements, carbohydrate, fat and low phenylalanine  Sachets containing oral powder 33.4 g, 30 (PKU GMPro Ultra)   Oral  PKU GMPro ULTRA   SB  MP NP  C4295     4  5     1

[146] Schedule 1, Part 1, entries for Ibuprofen in the form Tablet 400 mg
omit:
Ibuprofen  Tablet 400 mg  Oral  MEDICHOICE Ibuprofen 400 mg  NB  MP NP MW PDP                        30  0     30
Ibuprofen  Tablet 400 mg  Oral  MEDICHOICE Ibuprofen 400 mg  NB  PDP              P6256 P6282        90  0     30
Ibuprofen